FOCUSING ON UNIVERSAL THERAPIES FOR
ALL VARIANTS OF CORONA/FLU VIRUS
Driven by passion to fight corona/flu based diseases, we seek universal fast and effective therapies for humanity. With our new device PI-RNA, which uses our new Atmospheric Cold Plasma Technology (ACPT), we have strong evidence to suggest that our technology is able to inactivate presumably all variants of corona/flu virus through a gentle but fast-acting and effective application.
(ACPT) technology transmits a high number and density of atmospheric anions around and into the body produced by a special plasma design.
The non-invasive, gently and electrostatic transmitted atmospheric anions contain reactive electrons that interact with presumably all variants of corona/flu virus and render them inactive through a physical reaction.
UNIVERSAL POSSIBILITIES THROUGH UNIVERSAL APPROACH
In the scientific hypothesis anions are grouped around the spike proteins of the virus. The accumulation of anions around the spike proteins creates highly reactive hydroxyl radicals (OH·). The hydroxyl radicals react with the spike proteins and withdraw hydrogen from them, whereby water (H2O) is formed from the hydroxyl radicals (OH·) and hydrogen (H). The loss of the hydrogen damages the spike protein, which inactivates the virus. As a result the virus loses its ability to infect human cells.
Our technology represents a novel method which can enable a promising universal treatment of presumably all variants of corona/flu virus diseases. The company finalized the development of first prototypes for clinical use.
In a 2 Phase double blind observation study the company will evaluate effects in detail, safety and immunogenicity in management, treatment and control of COVID-19 and other RNA virus variants.